BEAM THERAPEUTICS INC shareholders Q3 2022

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

BEAM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 23,500$1,119,0000.36%
HighVista Strategies LLC 12,584$600,0000.34%
KRAEMATON INVESTMENT ADVISORS, INC 5,515$263,0000.34%
Eagle Health Investments LP 28,900$1,377,0000.32%
Yorktown Management & Research Co Inc 5,005$238,0000.31%
Nikko Asset Management Americas, Inc. 510,931$23,758,0000.30%
TANG CAPITAL MANAGEMENT LLC 50,000$2,382,0000.29%
Reynders McVeigh Capital Management, LLC 74,914$3,569,0000.28%
Eventide Asset Management 267,025$12,721,0000.25%
Quantamental Technologies LLC 13,354$636,0000.25%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 4,137$197,0000.21%
Granahan Investment Management 110,435$5,261,0000.17%
CAPITAL ADVISORS INC/OK 109,844$4,995,0000.16%
Rock Springs Capital Management LP 111,430$5,309,0000.14%
Pearl River Capital, LLC 15,455$736,0000.14%
Clarius Group, LLC 28,111$1,339,0000.13%
K.J. Harrison & Partners Inc 6,497$310,0000.11%
ClariVest Asset Management LLC 43,656$2,080,0000.10%
GILDER GAGNON HOWE & CO LLC 119,221$5,680,0000.10%
Family Management Corp 5,690$271,0000.07%
External links

This page lists BEAM THERAPEUTICS INC's shareholders in Q3 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.